Key result
GPIHBP1 acts as an endothelial cell transporter for lipoprotein lipase, and mutations in either GPIHBP1 or LPL that disrupt their interaction cause severe hypertriglyceridemia (chylomicronemia).
Population
GPIHBP1-deficient mice and humans with severe hypertriglyceridemia caused by GPIHBP1 or LPL mutations
Design
Review
Authors
Loading...
May warrant genetic evaluation in unexplained chylomicronemia; leaves open targeted interventions pending prospective data.
This review highlights the critical role of GPIHBP1 as an endothelial transporter for lipoprotein lipase and its genetic implications in severe hypertriglyceridemia.
Young et al. (2011) conducted a review in Severe hypertriglyceridemia (chylomicronemia). GPIHBP1 mutations was evaluated. GPIHBP1 acts as an endothelial cell transporter for lipoprotein lipase, and mutations in either GPIHBP1 or LPL that disrupt their interaction cause severe hypertriglyceridemia (chylomicronemia).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: